ARCHIVES

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

This article is from The Cancer Letter archive.

Vol. 23 No. 7 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Senate Outlines Budget Priorities In Bill Report

July 19, 1991

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

October 24, 1997

Clinical Cancer Research Battling Threats, Frei Says

May 15, 1981

Continuing Progress Reported On Breast Cancer Treatment; Mammography Controversy Cooled

November 26, 1976

Study Begins On Link Between Down Syndrome, Leukemia

May 28, 2004